ArticleOncotarget2015

Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma.

Ning Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.